Ambrx Biopharma
Ambrx Biopharma is a Healthcare & Life Sciences startup based in the United States, since acquired, 1 tracked investor.
About Ambrx Biopharma
Ambrx Biopharma is a startup based in the United States. Ambrx Biopharma has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ambrx Biopharma is a clinical-stage biopharmaceutical company that develops next-generation antibody-drug conjugates and engineered protein therapies using an expanded genetic code platform for oncology and immune modulation. It has advanced clinical programs including ARX517 and ARX788 and was acquired by Johnson & Johnson in March 2024.
Explore Ambrx Biopharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.